Paradigm Medical Earnings Estimate

Paradigm Medical Earnings per Share Projection vs Actual

About Paradigm Medical Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Paradigm Medical earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Paradigm Medical estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Paradigm Medical fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company was founded in 1989 and is based in Salt Lake City, Utah. Paradigm Medical operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 5 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Paradigm Pink Sheet

Paradigm Medical financial ratios help investors to determine whether Paradigm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Paradigm with respect to the benefits of owning Paradigm Medical security.